Order Article Reprints

Eiholzer RA, Mehta S, Kazantseva M, Drummond CJ, McKinney C, Young K, Slater D, Morten BC, Avery-Kiejda KA, Lasham A, et al. Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers. 2020; 12(9):2472. https://doi.org/10.3390/cancers12092472

Eiholzer, Ramona A., Sunali Mehta, Marina Kazantseva, Catherine J. Drummond, Cushla McKinney, Katie Young, David Slater, Brianna C. Morten, Kelly A. Avery-Kiejda, Annette Lasham, and et al. 2020. "Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk" Cancers 12, no. 9: 2472. https://doi.org/10.3390/cancers12092472

Eiholzer, R. A., Mehta, S., Kazantseva, M., Drummond, C. J., McKinney, C., Young, K., Slater, D., Morten, B. C., Avery-Kiejda, K. A., Lasham, A., Fleming, N., Morrin, H. R., Reader, K., Royds, J. A., Landmann, M., Petrich, S., Reddel, R., Huschtscha, L., Taha, A., ... Braithwaite, A. W. (2020). Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers, 12(9), 2472. https://doi.org/10.3390/cancers12092472